SRX3212
SRX3212 is a potent PI3Kα/BRD4 inhibitor with human IC50 values of 22 nM, 3.7 nM, and 32 nM for PI3Kα, BRD4BD1, and BRD4BD2, respectively. SRX3212 inhibits PI3K kinase activity and blocks acetyllysine binding function of BRD4BD1 and BRD4BD2. SRX3212 can be used for the research of mantle cell lymphoma, colon carcinoma, neuroblastoma, prostate cancer[1].
For research use only. We do not sell to patients.
- CAS No.: 2735720-80-4
- Formula: C26H23N3O6S
- Molecular Weight:505.54
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
PI3Kα 22 nM (IC50) |
BD1 3.7 nM (IC50) |
BD2 32 nM (IC50) |
In Vitro
SRX3212 potently inhibits purified BRD4BD1 (IC50 = 3.7 nM) and BRD4BD2 (IC50 = 32 nM) in an AlphaScreen displacement binding assay[1].
SRX3212 potently inhibits purified PI3Kα with an IC50 of 22 nM in a fluorescence-based kinase screening assay[1].
SRX3212 binds tightly to the hydrophobic pocket of purified BRD4BD1 via multiple conserved and unique interactions, acting as an acetyllysine mimetic to drive high binding potency[1].
SRX3212 (48 hours) potently inhibits viability of JeKo-1 (IC50 = 0.28 μM), Mino (IC50 = 0.44 μM), and Z138 (IC50 = 0.24 μM) mantle cell lymphoma cell lines, HCT116 colon carcinoma cells (IC50 = 1.3 μM), and SKNBE-2 neuroblastoma cells (IC50 = 3.2 μM), but does not inhibit PC3 prostate cancer cell viability[1].
SRX3212 (0.5-5 μM; 1 hour) inhibits PI3K activity in JeKo-1 mantle cell lymphoma cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:JeKo-1 mantle cell lymphoma cell line
-
Concentration:0.5 μM; 1 μM; 2.5 μM; 5 μM
-
Incubation Time:1 hour
-
Result:Caused a concomitant decrease in AKT phosphorylation at Ser473 with increasing concentrations, indicating reduced PI3K activity.
Chemical Information
-
CAS No. 2735720-80-4
-
Molecular Weight 505.54
-
Formula C26H23N3O6S
-
SMILES
O=C1C=C(N2CCOCC2)OC3=C1SC=C3C4=CC(C(NCC5=CC=CN=C5)=O)=C6OCCOC6=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Kinase activity and phosphorylation assays
Kinase activity assays measure the ability of kinases to transfer phosphate groups from ATP to specific substrates, while phosphorylation assays detect the presence and levels of phosphorylated proteins. Common methods include radiolabeled ATP incorporation (e. g. ,), ADP release detection via bioluminescence (e. g. ,[3]), enzyme-linked immunosorbent assays (ELISA) for phospho-specific epitopes (e. g. ,[6]), and microtiter-based formats for high-throughput screening (e. g. ,[8]). The ADP-Glo assay quantifies kinase activity by measuring ADP produced during phosphorylation using a luciferase-based system. Radiometric assays involve autoradiography or scintillation counting after incorporation of 32P-labeled ATP into substrate proteins. ELISA-based approaches rely on phospho-specific antibodies to detect activated kinases in cell lysates or purified samples.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Protocol for Kinase activity and phosphorylation assays
Kinase activity assays measure transfer of phosphate from ATP to a protein or peptide substrate, generating phosphorylated substrate, ADP, or incorporated radiolabeled phosphate as the readout; phosphorylation assays measure site-specific phosphorylation in cells or tissues as a proxy for kinase-pathway activation, inhibition, or substrate regulation. Phosphorylation can be detected by phospho-specific Western blot, immunoprecipitation kinase assay, phospho-immunofluorescence, phospho-flow cytometry, luminescent ADP detection, radiolabeled ATP incorporation, or reporter-based pathway assays, and these readouts can be applied to cancer cells, primary neurons, mouse tumors, organoids, inflammatory macrophages, ferroptosis studies, and mitophagy studies when the kinase target is biologically relevant.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)